Category: Reviews
-
September A&R Roundup
At long last, it’s time for the September Roundup of Arthritis & Rheumatism, the premier(?) journal for all things rheumatologic. Sorry it took me so long; I will plead that it was a very busy month, and that the paper journal took a long time to come out. I should also note that abstracts for…
-
Follow-up to A&R Letter
This is a quick follow-up to this post from a couple of days ago. I’ve now read the two articles referred to, and agree that there’s some funny stuff going on here. I don’t really doubt the conclusions, but I think the authors really do have to explain some things.
-
Follow-up to A&R Letter
This is a quick follow-up to this post from a couple of days ago. I’ve now read the two articles referred to, and agree that there’s some funny stuff going on here. I don’t really doubt the conclusions, but I think the authors really do have to explain some things.
-
Sept A&R is Out – Check Out This Letter!
This month’s Arthritis and Rheumatism is now available, on line at least. I’m not sure why I didn’t get the TOC email, but I found out through the grape vine and have taken a preliminary look through it. Sorry, you can only read it if you have a prescription. Jumping Jehosephat! It’s packed with good…
-
Celecoxib and Cardiovascular Risk
Finally, I’m getting around to reviewing the two articles I’ve been threatening to review for the last week! I’m referring to two articles published in the New England Journal of Medicine last week. Both are about reducing the risk of colon polyps by using celecoxib (Celebrex). The fact is that these articles are interesting not…
-
Celecoxib and Cardiovascular Risk
Finally, I’m getting around to reviewing the two articles I’ve been threatening to review for the last week!I’m referring to two articles published in the New England Journal of Medicine last week. Both are about reducing the risk of colon polyps by using celecoxib (Celebrex). The fact is that these articles are interesting not because…
-
Alendronate for GC-induced bone loss
There are two articles in last week’s New England Journal of Medicine worth looking at (login required for access): one is a randomized trial of alendronate in glucocorticoid-induced osteoporosis, and the other is a review article of Paget’s disease of bone. I want to review the first of these here (N Engl J Med 2006;355(7):675-684).…
-
August A&R Roundup
This is my personal, highly selective take on articles in the August Arthritis & Rheumatism. Login is required if you want to read the actual articles – I frequently have trouble loggin on to their site anyway. There is an article about TNF antagonists in pregnancy with an accompanying editorial by Jane Salmon & Deborah…
Steven Vlad 